drugset / Trial / NCT01720095

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

NCT01720095

Phase 3 Completed 22 enrolled Nova Scotia Health Authority
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to help understand if by adding Niaspan FCT (study drug) to antipsychotic medications will it help maintain or improve cognitve functioning.

Timeline

Start
2009-10
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule

Indications